Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
MicroLife is Scopus-indexed (Q2, CiteScore 5.8), WoS ESCI, DOAJ. Published by Oxford University Press.
Checked against the index lists dated .
ISSN 2633-6693Verify ISSN ↗
Publisher: Oxford University Press
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Microbiology (all) | 19 / 63 | 70th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q2, CiteScore 5.8.
MicroLife is Q2 in Immunology and Microbiology (all) (rank 19 of 63), by CiteScore 2025.
MicroLife is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.8, which places it in quartile Q2 at the 70th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.758, quartile Q1, with an H-index of 16.
The publisher lists an article processing charge of about US$3,297 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
MicroLife is published by Oxford University Press. Its ISSN is 2633-6693.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
MicroLife has an h-index of 24 and a 2-year mean of 2.87 citations per paper (OpenAlex). Its Scopus CiteScore is 5.8, quartile Q2. On 2-year citations it ranks #20 of 62 Scopus journals in Immunology and Microbiology (all).
MicroLife published 47 papers in 2025; its busiest recent year was 2023 with 49. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2024–2026), authors are most often from Germany (50%), France (10.8%) and United Kingdom (7.4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.